We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Gain an understanding of the Groceries Code Adjudicator's interpretation of parts of the Groceries Supply Code of Practice.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
Answering supplier questions, or 'clarification' questions, on the Digital Marketplace.
This tax information and impact note illustrates the intention on capital allowances relating to the cost of land alterations.
Where we feel that our work is misrepresented, we may seek clarification or correction.
How to use a contextual inquiry when developing your digital health product.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
This guidance provides clarification of the MCA's Dyslexia Policy and considers up to date guidance from the Joint Council for Qualifications (JCQ) while maintaining compliance with STCW requirements.
Regulated community should use the Military Aviation Authority request for change form to propose changes to regulatory articles or associated manuals.
This tax information and impact note applies to individuals, partners ,trustees, and certain beneficiaries of deceased persons estates to whom the finance costs restriction applies.
Clarification from the Office of the Immigration Services Commissioner (the OISC) in relation to its jurisdiction.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Lists of standards that businesses can use to show their products, services or processes comply with essential requirements of legislation.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Form PF57: Application for further information or clarification (Rule 18 and Practice Direction 18, para 5).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).